Ernexa Therapeutics (ERNAW) Net Margin (2010 - 2024)
Ernexa Therapeutics (ERNAW) reported Net Margin of 30352.63% for Q4 2024, down 1777916.0% on a YoY basis from N/an in Q1 2024, and down 455.62% quarter-over-quarter from 5462.83% in Q3 2024.
Ernexa Therapeutics (ERNAW) Net Margin (2010 - 2024) Analysis & Trends
Ernexa Therapeutics has reported Net Margin for 13 years, with the latest figure at 30352.63% in Q4 2024.
- For the quarter ending Q4 2024, Net Margin fell 1777916.0% year-over-year to 30352.63%; the trailing twelve-month figure through Dec 2024 stood at 7425.83% (up 1425817.0% YoY), and the FY2024 full-year result was 7425.83%, up 1425817.0% from the prior year.
- Net Margin for Q4 2024 stood at 30352.63%, down from 5462.83% in the prior quarter.
- The five-year high for Net Margin was 50.88% in Q1 2020, with the low at 30352.63% in Q4 2024.
- Historically, Net Margin has averaged 9516.84% across 3 years, with a median of 10962.75% in 2023.
- The largest YoY upside for Net Margin was 549991 bps in 2024 against a maximum downside of 1777916 bps in 2024.
- Ernexa Therapeutics' Net Margin stood at 188.78% in 2020, then sank by 6560 bps to 12573.47% in 2023, then sank by 141 bps to 30352.63% in 2024.
- The last three Net Margin figures came in at 30352.63% (Q4 2024), 5462.83% (Q3 2024), and 11780.85% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -30,352.63% |
| Sep 30, 2024 | -5,462.83% |
| Jun 30, 2024 | -11,780.85% |
| Mar 31, 2024 | -14,142.55% |
| Dec 31, 2023 | -12,573.47% |
| Sep 30, 2023 | -10,962.75% |
| Dec 31, 2020 | -188.78% |
| Sep 30, 2020 | -136.77% |
| Mar 31, 2020 | -50.88% |
| Dec 31, 2019 | -25.17% |
| Sep 30, 2019 | -7.66% |
| Jun 30, 2019 | -1.88% |
| Mar 31, 2019 | -6.48% |
| Dec 31, 2018 | 0.74% |
| Sep 30, 2018 | 3.70% |
| Jun 30, 2018 | -2.19% |
| Mar 31, 2018 | -7.10% |
| Dec 31, 2017 | -6.11% |
| Sep 30, 2017 | -3.54% |
| Jun 30, 2017 | -2.96% |